Tech Goes Home Chattanooga reaches 25,000 graduates
The free 15-hour digital-skills course comes with a device to take home. Its most popular class shows older adults how to use telehealth, a calendar, and video calls.
Read the original
The reporting lives at Chattanooga Times Free Press. Our summary is checked against it, and we link it on every story.
Tech Goes Home has graduated 25,000 people from its free digital-skills classes, the Chattanooga Times Free Press reported. The program, part of the Chattanooga-based Enterprise Center, gives a device to each person who finishes a 15-hour course. Director Melissa Callejas said it has partnered with more than 200 organizations since it began in Chattanooga in 2015. It expanded across Tennessee in 2021 and into Georgia and Alabama this year.
The menu includes workforce skills and college and career readiness. The most requested class is for older adults learning telehealth, a digital calendar for appointments, and video calls with family. Other sessions, including ones with ArtsBuild, show younger artists how to build a site and present their work. The milestone is a count of people who finished the hours and left with a device, not a claim that a class replaces medical care.
For the classroom
Tech Goes Home, a program of the Enterprise Center in Chattanooga, has now graduated 25,000 people. Anyone who finishes a free 15-hour class gets a device to take home. Classes cover work skills, college and career planning, and tools for artists. The most popular class is for older adults. They learn how to use telehealth, keep appointments on a digital calendar, and make video calls with family. The program started in Chattanooga in 2015, spread across Tennessee in 2021, and reached Georgia and Alabama this year. It has worked with more than 200 organizations.
- Why would a class give someone a computer instead of only lending one?
- What is one thing a video call can do that a phone call cannot?
- Who in your family might like a class on using a doctor's visit from home?
For a teacher to read with a class. Print the story of the day · All classroom stories
More good news
Other stories in the same neighborhood of kindness.
Health & TechA personalised melanoma vaccine cut the risk of cancer returning in a large trial
In 1,137 adults, Intismeran plus immunotherapy lowered the chance of death or melanoma returning by 42 percent at two years. It is not approved, and the results are not peer-reviewed yet.
Verified · BBC News
Health & TechAn early T-cell trial stalled tumors in patients whose cancers had resisted immunotherapy
In an NIH-led phase 1/2 trial published in Nature Medicine, invikafusp alfa stopped progression in 16 of 27 patients at the optimal dose and shrank tumors in four. These are early results, not a cure.
Verified · National Institutes of Health
Health & TechThe FDA approves the first once-weekly insulin for children with type 2 diabetes
Awiqli, insulin icodec, is now cleared for patients 10 and older with type 2 diabetes, along with diet and exercise. It replaces a daily basal shot with one a week.
Verified · U.S. Food and Drug Administration